Cargando…
One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology
Background: The t:slim X2™ insulin pump with Control-IQ(®) technology from Tandem Diabetes Care is an advanced hybrid closed-loop system that was first commercialized in the United States in January 2020. Longitudinal glycemic outcomes associated with real-world use of this system have yet to be rep...
Autores principales: | Breton, Marc D., Kovatchev, Boris P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501470/ https://www.ncbi.nlm.nih.gov/pubmed/33784196 http://dx.doi.org/10.1089/dia.2021.0097 |
Ejemplares similares
-
Virtual Pump Trainings for the t:slim X2 Insulin Pump With Control-IQ Advanced Hybrid Closed-Loop Technology: Real World Patient Experience
por: Singh, Harsimran, et al.
Publicado: (2021) -
Closed loop control for type 1 diabetes
por: Kovatchev, Boris
Publicado: (2011) -
Automated closed-loop control of diabetes: the artificial pancreas
por: Kovatchev, Boris
Publicado: (2018) -
Real-World Evidence Supporting Tandem Control-IQ Hybrid Closed-Loop Success in the Medicare and Medicaid Type 1 and Type 2 Diabetes Populations
por: Forlenza, Gregory P., et al.
Publicado: (2022) -
Real-World Patient-Reported Outcomes and Glycemic Results with Initiation of Control-IQ Technology
por: Pinsker, Jordan E., et al.
Publicado: (2021)